Sharekhan is bullish on Strides Pharma Sciences has recommended buy rating on the stock with a target price of Rs 450 in its research report dated November 15, 2022.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
Sharekhan is bullish on Strides Pharma Sciences has recommended buy rating on the stock with a target price of Rs 450 in its research report dated November 15, 2022.
| Subscribe To Our Free Newsletter |
